文献类型：期刊文章

作　　者：司书毅[1] 黄明玉[1] 张月琴[1]

机构地区：[1]中国医学科学院中国协和医科大学医药生物技术研究所国家新药筛选实验室,北京100050

出　　处：《基础医学与临床》

年　　份：2001

卷　　号：21

期　　号：4

起止页码：294-297

语　　种：中文

收录情况：BDHX、BDHX2000、CSCD、CSCD2011_2012、ZGKJHX、核心刊

摘　　要：Microbial drugs are antibiotics and other pharmacological substances from the secondary metabolites of microorganisms Screening process includes collection of soil and ocean samples, isolation of microorganisms, fermentation, strain screening, isolation of bioactive components and structure elucidation Producing microorganisms includes streptomyces, rare actinomycetes, bacteria, fungi, and ocean microorganisms New strategy for screening new microbial drugs is the screening of novel anti resistant bacterial agents, antifungal agents, antiviral agents, antitumor substances, immunomodulators and pharmacological active

关 键 词：微生物药物 药物筛选 样品  微生物 发酵液 抗生素

分 类 号：R965.1]